{
    "eid": "2-s2.0-85153720188",
    "title": "Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations",
    "cover-date": "2023-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "antipsychotics",
        "rating scales",
        "recommendations",
        "tardive",
        "tardive dyskinesia"
    ],
    "authors": [
        "Davide Martino",
        "Vikram Karnik",
        "Roongroj Bhidayasiri",
        "Deborah A. Hall",
        "Robert A. Hauser",
        "Antonella Macerollo",
        "Tamara M. Pringsheim",
        "Daniel Truong",
        "Stewart A. Factor",
        "Matej Skorvanek",
        "Anette Schrag",
        "Matej Skorvanek",
        "Michelle H.S. Tosin",
        "Aparna Wagle Shukla",
        "Alberto Espay",
        "Ruey Meei Wu",
        "Norbert Kovacs",
        "Wassilios Meissner",
        "Galit Kleiner",
        "Ioanna Markaki",
        "Anette Schrag",
        "Daniel Weintraub"
    ],
    "citedby-count": 2,
    "ref-count": 44,
    "ref-list": [
        "Antipsychotic-induced tardive dyskinesia: update on epidemiology and management",
        "Current management of Tics and Tourette syndrome: behavioral, pharmacologic, and surgical treatments",
        "Tardive syndromes",
        "Impact of drug-induced parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia",
        "The lesser of two evils: a qualitative study of quetiapine prescribing by family physicians",
        "Tardive dyskinesia: therapeutic options for an increasingly common disorder",
        "Antipsychotic-induced extrapyramidal side effects: a systematic review and meta-analysis of observational studies",
        "Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis",
        "Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice",
        "Recent developments in drug-induced movement disorders: a mixed picture",
        "Movement disorders associated with antipsychotic medication in people with schizophrenia: an overview of Cochrane reviews and meta-analysis",
        "Management of tardive syndrome: medications and surgical treatments",
        "Expanding phenomenologic heterogeneity of tardive syndromes: time for an updated assessment tool",
        "The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content",
        "The extrapyramidal symptoms rating scale",
        "A rating scale for drug-induced akathisia",
        "Assessment of tardive dyskinesia using the abnormal involuntary movement scale",
        "The Maryland psychiatric research center scale and the characterization of involuntary movements",
        "A rating scale for extrapyramidal side effects",
        "Reliability of the Matson evaluation of drug side effects scale (MEDS)",
        "Psychometric properties of the dyskinesia identification system: condensed user scale (DISCUS)",
        "A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients",
        "The St. Hans rating scale for extrapyramidal syndromes: reliability and validity",
        "A new self-rating scale for detecting atypical or second-generation antipsychotic side effects",
        "The schedule for the assessment of drug-induced movement disorders (SADIMoD): test-retest reliability and concurrent validity",
        "Assessment of extrapyramidal symptoms during acute neuroleptic treatment",
        "The nosology of tardive syndromes",
        "Characteristics of patients experiencing extrapyramidal symptoms or other movement disorders related to dopamine receptor blocking agent therapy",
        "Schizophrenia: antipsychotics and drug development",
        "Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial",
        "A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients",
        "Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial",
        "KINECT 3: a phase 3 randomized, double-blind, placebo-controlled trial of Valbenazine for tardive dyskinesia",
        "Abnormal involuntary movement scale in tardive dyskinesia: minimal clinically important difference",
        "Minimal clinically important change in abnormal involuntary movement scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazine",
        "Classification of movement disorders",
        "Setting the record straight: the nosology of tardive syndromes",
        "Validity and reliability of a rating scale for the primary torsion dystonias",
        "Movement Disorder Society task force on rating scales for Parkinson's disease. The unified Parkinson's disease rating scale (UPDRS): status and recommendations",
        "SMARTS (systematic monitoring of adverse events related to TreatmentS): the development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects",
        "Development and psychometric assessment of a nurse-administered screening tool for movement disorders in psychosis",
        "Movement disorders induced by psychiatric drugs that do not block dopamine receptors",
        "Comparison of the Fahn-Tolosa-Marin clinical rating scale and the essential tremor rating assessment scale"
    ],
    "affiliation": [
        {
            "affiliation-city": "Calgary",
            "@id": "60000953",
            "affilname": "Cumming School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000953",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Calgary",
            "@id": "60192961",
            "affilname": "Alberta Children\u2019s Hospital Research Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60192961",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Calgary",
            "@id": "60192954",
            "affilname": "Hotchkiss Brain Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60192954",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Liverpool",
            "@id": "60160417",
            "affilname": "The Walton Centre NHS Foundation Trust",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60160417",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Kosice",
            "@id": "60104469",
            "affilname": "Louis Pasteur University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60104469",
            "affiliation-country": "Slovakia"
        },
        {
            "affiliation-city": "Fountain Valley",
            "@id": "60087785",
            "affilname": "Parkinson's and Movement Disorder Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60087785",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Kosice",
            "@id": "60031236",
            "affilname": "Pavol Jozef \u0160af\u00e1rik University in Ko\u0161ice",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031236",
            "affiliation-country": "Slovakia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Liverpool",
            "@id": "60020661",
            "affilname": "University of Liverpool",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020661",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "London",
            "@id": "60019953",
            "affilname": "UCL Queen Square Institute of Neurology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019953",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Chicago",
            "@id": "60018691",
            "affilname": "Rush University Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018691",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Tampa",
            "@id": "60007740",
            "affilname": "University of South Florida, Tampa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007740",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Atlanta",
            "@id": "60002339",
            "affilname": "Emory University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002339",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "113736755",
            "affilname": "Academy of Science",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/113736755",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Calgary",
            "@id": "112672043",
            "affilname": "Mathison Centre for Mental Health Research and Education",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112672043",
            "affiliation-country": "Canada"
        }
    ],
    "funding": [
        "National Institutes of Health",
        "National Institute of Neurological Disorders and Stroke",
        "Michael J. Fox Foundation",
        "International Parkinson and Movement Disorders Society",
        "Public Health Agency of Canada",
        "Alberta Children's Hospital Research Institute",
        "Canadian Institutes of Health Research",
        "Alberta Health"
    ]
}